Global Neurologic Disorder Treatment Drug Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Neurologic Disorder Treatment Drug market size was estimated at USD 60542.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurologic Disorder Treatment Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurologic Disorder Treatment Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurologic Disorder Treatment Drug market.
Global Neurologic Disorder Treatment Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AbbVie
Acadia Pharmaceuticals
Acorda Therapeutics Biotechnology
Bayer
Biogen
CSK
Eisai
F. Hoffmann La Roche
H Lundbeck
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
UCB
USWM
Market Segmentation (by Type)
Anticholinergic
Antiepileptic
Antipsychotic
Hypnotic and Sedative
Analgesics
Antihypertensive
Anticoagulants
Others
Market Segmentation (by Application)
Epilepsy
Alzheimer?s Disease
Parkinson's Disease
Multiple Sclerosis
Cerebrovascular Disease
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurologic Disorder Treatment Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurologic Disorder Treatment Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neurologic Disorder Treatment Drug market size was estimated at USD 60542.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.25% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neurologic Disorder Treatment Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neurologic Disorder Treatment Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neurologic Disorder Treatment Drug market.
Global Neurologic Disorder Treatment Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AbbVie
Acadia Pharmaceuticals
Acorda Therapeutics Biotechnology
Bayer
Biogen
CSK
Eisai
F. Hoffmann La Roche
H Lundbeck
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
UCB
USWM
Market Segmentation (by Type)
Anticholinergic
Antiepileptic
Antipsychotic
Hypnotic and Sedative
Analgesics
Antihypertensive
Anticoagulants
Others
Market Segmentation (by Application)
Epilepsy
Alzheimer?s Disease
Parkinson's Disease
Multiple Sclerosis
Cerebrovascular Disease
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neurologic Disorder Treatment Drug Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurologic Disorder Treatment Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neurologic Disorder Treatment Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurologic Disorder Treatment Drug
1.2 Key Market Segments
1.2.1 Neurologic Disorder Treatment Drug Segment by Type
1.2.2 Neurologic Disorder Treatment Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGIC DISORDER TREATMENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurologic Disorder Treatment Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neurologic Disorder Treatment Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGIC DISORDER TREATMENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurologic Disorder Treatment Drug Product Life Cycle
3.3 Global Neurologic Disorder Treatment Drug Sales by Manufacturers (2020-2025)
3.4 Global Neurologic Disorder Treatment Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurologic Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurologic Disorder Treatment Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neurologic Disorder Treatment Drug Market Competitive Situation and Trends
3.8.1 Neurologic Disorder Treatment Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neurologic Disorder Treatment Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROLOGIC DISORDER TREATMENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Neurologic Disorder Treatment Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGIC DISORDER TREATMENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurologic Disorder Treatment Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neurologic Disorder Treatment Drug Market
5.7 ESG Ratings of Leading Companies
6 NEUROLOGIC DISORDER TREATMENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurologic Disorder Treatment Drug Sales Market Share by Type (2020-2025)
6.3 Global Neurologic Disorder Treatment Drug Market Size by Type (2020-2025)
6.4 Global Neurologic Disorder Treatment Drug Price by Type (2020-2025)
7 NEUROLOGIC DISORDER TREATMENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurologic Disorder Treatment Drug Market Sales by Application (2020-2025)
7.3 Global Neurologic Disorder Treatment Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Neurologic Disorder Treatment Drug Sales Growth Rate by Application (2020-2025)
8 NEUROLOGIC DISORDER TREATMENT DRUG MARKET SALES BY REGION
8.1 Global Neurologic Disorder Treatment Drug Sales by Region
8.1.1 Global Neurologic Disorder Treatment Drug Sales by Region
8.1.2 Global Neurologic Disorder Treatment Drug Sales Market Share by Region
8.2 Global Neurologic Disorder Treatment Drug Market Size by Region
8.2.1 Global Neurologic Disorder Treatment Drug Market Size by Region
8.2.2 Global Neurologic Disorder Treatment Drug Market Size by Region
8.3 North America
8.3.1 North America Neurologic Disorder Treatment Drug Sales by Country
8.3.2 North America Neurologic Disorder Treatment Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neurologic Disorder Treatment Drug Sales by Country
8.4.2 Europe Neurologic Disorder Treatment Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neurologic Disorder Treatment Drug Sales by Region
8.5.2 Asia Pacific Neurologic Disorder Treatment Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neurologic Disorder Treatment Drug Sales by Country
8.6.2 South America Neurologic Disorder Treatment Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neurologic Disorder Treatment Drug Sales by Region
8.7.2 Middle East and Africa Neurologic Disorder Treatment Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROLOGIC DISORDER TREATMENT DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Neurologic Disorder Treatment Drug by Region(2020-2025)
9.2 Global Neurologic Disorder Treatment Drug Revenue Market Share by Region (2020-2025)
9.3 Global Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neurologic Disorder Treatment Drug Production
9.4.1 North America Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.4.2 North America Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neurologic Disorder Treatment Drug Production
9.5.1 Europe Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.5.2 Europe Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neurologic Disorder Treatment Drug Production (2020-2025)
9.6.1 Japan Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.6.2 Japan Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neurologic Disorder Treatment Drug Production (2020-2025)
9.7.1 China Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.7.2 China Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Neurologic Disorder Treatment Drug Product Overview
10.1.3 AbbVie Neurologic Disorder Treatment Drug Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Acadia Pharmaceuticals
10.2.1 Acadia Pharmaceuticals Basic Information
10.2.2 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Overview
10.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Market Performance
10.2.4 Acadia Pharmaceuticals Business Overview
10.2.5 Acadia Pharmaceuticals SWOT Analysis
10.2.6 Acadia Pharmaceuticals Recent Developments
10.3 Acorda Therapeutics Biotechnology
10.3.1 Acorda Therapeutics Biotechnology Basic Information
10.3.2 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Overview
10.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Market Performance
10.3.4 Acorda Therapeutics Biotechnology Business Overview
10.3.5 Acorda Therapeutics Biotechnology SWOT Analysis
10.3.6 Acorda Therapeutics Biotechnology Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer Neurologic Disorder Treatment Drug Product Overview
10.4.3 Bayer Neurologic Disorder Treatment Drug Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Biogen
10.5.1 Biogen Basic Information
10.5.2 Biogen Neurologic Disorder Treatment Drug Product Overview
10.5.3 Biogen Neurologic Disorder Treatment Drug Product Market Performance
10.5.4 Biogen Business Overview
10.5.5 Biogen Recent Developments
10.6 CSK
10.6.1 CSK Basic Information
10.6.2 CSK Neurologic Disorder Treatment Drug Product Overview
10.6.3 CSK Neurologic Disorder Treatment Drug Product Market Performance
10.6.4 CSK Business Overview
10.6.5 CSK Recent Developments
10.7 Eisai
10.7.1 Eisai Basic Information
10.7.2 Eisai Neurologic Disorder Treatment Drug Product Overview
10.7.3 Eisai Neurologic Disorder Treatment Drug Product Market Performance
10.7.4 Eisai Business Overview
10.7.5 Eisai Recent Developments
10.8 F. Hoffmann La Roche
10.8.1 F. Hoffmann La Roche Basic Information
10.8.2 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Overview
10.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Market Performance
10.8.4 F. Hoffmann La Roche Business Overview
10.8.5 F. Hoffmann La Roche Recent Developments
10.9 H Lundbeck
10.9.1 H Lundbeck Basic Information
10.9.2 H Lundbeck Neurologic Disorder Treatment Drug Product Overview
10.9.3 H Lundbeck Neurologic Disorder Treatment Drug Product Market Performance
10.9.4 H Lundbeck Business Overview
10.9.5 H Lundbeck Recent Developments
10.10 Johnson and Johnson
10.10.1 Johnson and Johnson Basic Information
10.10.2 Johnson and Johnson Neurologic Disorder Treatment Drug Product Overview
10.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Product Market Performance
10.10.4 Johnson and Johnson Business Overview
10.10.5 Johnson and Johnson Recent Developments
10.11 Merck
10.11.1 Merck Basic Information
10.11.2 Merck Neurologic Disorder Treatment Drug Product Overview
10.11.3 Merck Neurologic Disorder Treatment Drug Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Novartis
10.12.1 Novartis Basic Information
10.12.2 Novartis Neurologic Disorder Treatment Drug Product Overview
10.12.3 Novartis Neurologic Disorder Treatment Drug Product Market Performance
10.12.4 Novartis Business Overview
10.12.5 Novartis Recent Developments
10.13 Otsuka Pharmaceutical
10.13.1 Otsuka Pharmaceutical Basic Information
10.13.2 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
10.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Market Performance
10.13.4 Otsuka Pharmaceutical Business Overview
10.13.5 Otsuka Pharmaceutical Recent Developments
10.14 Pfizer
10.14.1 Pfizer Basic Information
10.14.2 Pfizer Neurologic Disorder Treatment Drug Product Overview
10.14.3 Pfizer Neurologic Disorder Treatment Drug Product Market Performance
10.14.4 Pfizer Business Overview
10.14.5 Pfizer Recent Developments
10.15 Sanofi
10.15.1 Sanofi Basic Information
10.15.2 Sanofi Neurologic Disorder Treatment Drug Product Overview
10.15.3 Sanofi Neurologic Disorder Treatment Drug Product Market Performance
10.15.4 Sanofi Business Overview
10.15.5 Sanofi Recent Developments
10.16 Takeda Pharmaceutical
10.16.1 Takeda Pharmaceutical Basic Information
10.16.2 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
10.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Market Performance
10.16.4 Takeda Pharmaceutical Business Overview
10.16.5 Takeda Pharmaceutical Recent Developments
10.17 Teva Pharmaceutical Industries
10.17.1 Teva Pharmaceutical Industries Basic Information
10.17.2 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Overview
10.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Market Performance
10.17.4 Teva Pharmaceutical Industries Business Overview
10.17.5 Teva Pharmaceutical Industries Recent Developments
10.18 UCB
10.18.1 UCB Basic Information
10.18.2 UCB Neurologic Disorder Treatment Drug Product Overview
10.18.3 UCB Neurologic Disorder Treatment Drug Product Market Performance
10.18.4 UCB Business Overview
10.18.5 UCB Recent Developments
10.19 USWM
10.19.1 USWM Basic Information
10.19.2 USWM Neurologic Disorder Treatment Drug Product Overview
10.19.3 USWM Neurologic Disorder Treatment Drug Product Market Performance
10.19.4 USWM Business Overview
10.19.5 USWM Recent Developments
11 NEUROLOGIC DISORDER TREATMENT DRUG MARKET FORECAST BY REGION
11.1 Global Neurologic Disorder Treatment Drug Market Size Forecast
11.2 Global Neurologic Disorder Treatment Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurologic Disorder Treatment Drug Market Size Forecast by Country
11.2.3 Asia Pacific Neurologic Disorder Treatment Drug Market Size Forecast by Region
11.2.4 South America Neurologic Disorder Treatment Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neurologic Disorder Treatment Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neurologic Disorder Treatment Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neurologic Disorder Treatment Drug by Type (2026-2035)
12.1.2 Global Neurologic Disorder Treatment Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neurologic Disorder Treatment Drug by Type (2026-2035)
12.2 Global Neurologic Disorder Treatment Drug Market Forecast by Application (2026-2035)
12.2.1 Global Neurologic Disorder Treatment Drug Sales (K MT) Forecast by Application
12.2.2 Global Neurologic Disorder Treatment Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurologic Disorder Treatment Drug
1.2 Key Market Segments
1.2.1 Neurologic Disorder Treatment Drug Segment by Type
1.2.2 Neurologic Disorder Treatment Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGIC DISORDER TREATMENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurologic Disorder Treatment Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neurologic Disorder Treatment Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGIC DISORDER TREATMENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neurologic Disorder Treatment Drug Product Life Cycle
3.3 Global Neurologic Disorder Treatment Drug Sales by Manufacturers (2020-2025)
3.4 Global Neurologic Disorder Treatment Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurologic Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurologic Disorder Treatment Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neurologic Disorder Treatment Drug Market Competitive Situation and Trends
3.8.1 Neurologic Disorder Treatment Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neurologic Disorder Treatment Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROLOGIC DISORDER TREATMENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Neurologic Disorder Treatment Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGIC DISORDER TREATMENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neurologic Disorder Treatment Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neurologic Disorder Treatment Drug Market
5.7 ESG Ratings of Leading Companies
6 NEUROLOGIC DISORDER TREATMENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurologic Disorder Treatment Drug Sales Market Share by Type (2020-2025)
6.3 Global Neurologic Disorder Treatment Drug Market Size by Type (2020-2025)
6.4 Global Neurologic Disorder Treatment Drug Price by Type (2020-2025)
7 NEUROLOGIC DISORDER TREATMENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurologic Disorder Treatment Drug Market Sales by Application (2020-2025)
7.3 Global Neurologic Disorder Treatment Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Neurologic Disorder Treatment Drug Sales Growth Rate by Application (2020-2025)
8 NEUROLOGIC DISORDER TREATMENT DRUG MARKET SALES BY REGION
8.1 Global Neurologic Disorder Treatment Drug Sales by Region
8.1.1 Global Neurologic Disorder Treatment Drug Sales by Region
8.1.2 Global Neurologic Disorder Treatment Drug Sales Market Share by Region
8.2 Global Neurologic Disorder Treatment Drug Market Size by Region
8.2.1 Global Neurologic Disorder Treatment Drug Market Size by Region
8.2.2 Global Neurologic Disorder Treatment Drug Market Size by Region
8.3 North America
8.3.1 North America Neurologic Disorder Treatment Drug Sales by Country
8.3.2 North America Neurologic Disorder Treatment Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neurologic Disorder Treatment Drug Sales by Country
8.4.2 Europe Neurologic Disorder Treatment Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neurologic Disorder Treatment Drug Sales by Region
8.5.2 Asia Pacific Neurologic Disorder Treatment Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neurologic Disorder Treatment Drug Sales by Country
8.6.2 South America Neurologic Disorder Treatment Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neurologic Disorder Treatment Drug Sales by Region
8.7.2 Middle East and Africa Neurologic Disorder Treatment Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROLOGIC DISORDER TREATMENT DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Neurologic Disorder Treatment Drug by Region(2020-2025)
9.2 Global Neurologic Disorder Treatment Drug Revenue Market Share by Region (2020-2025)
9.3 Global Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neurologic Disorder Treatment Drug Production
9.4.1 North America Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.4.2 North America Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neurologic Disorder Treatment Drug Production
9.5.1 Europe Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.5.2 Europe Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neurologic Disorder Treatment Drug Production (2020-2025)
9.6.1 Japan Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.6.2 Japan Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neurologic Disorder Treatment Drug Production (2020-2025)
9.7.1 China Neurologic Disorder Treatment Drug Production Growth Rate (2020-2025)
9.7.2 China Neurologic Disorder Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Neurologic Disorder Treatment Drug Product Overview
10.1.3 AbbVie Neurologic Disorder Treatment Drug Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Acadia Pharmaceuticals
10.2.1 Acadia Pharmaceuticals Basic Information
10.2.2 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Overview
10.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Market Performance
10.2.4 Acadia Pharmaceuticals Business Overview
10.2.5 Acadia Pharmaceuticals SWOT Analysis
10.2.6 Acadia Pharmaceuticals Recent Developments
10.3 Acorda Therapeutics Biotechnology
10.3.1 Acorda Therapeutics Biotechnology Basic Information
10.3.2 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Overview
10.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Market Performance
10.3.4 Acorda Therapeutics Biotechnology Business Overview
10.3.5 Acorda Therapeutics Biotechnology SWOT Analysis
10.3.6 Acorda Therapeutics Biotechnology Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer Neurologic Disorder Treatment Drug Product Overview
10.4.3 Bayer Neurologic Disorder Treatment Drug Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Biogen
10.5.1 Biogen Basic Information
10.5.2 Biogen Neurologic Disorder Treatment Drug Product Overview
10.5.3 Biogen Neurologic Disorder Treatment Drug Product Market Performance
10.5.4 Biogen Business Overview
10.5.5 Biogen Recent Developments
10.6 CSK
10.6.1 CSK Basic Information
10.6.2 CSK Neurologic Disorder Treatment Drug Product Overview
10.6.3 CSK Neurologic Disorder Treatment Drug Product Market Performance
10.6.4 CSK Business Overview
10.6.5 CSK Recent Developments
10.7 Eisai
10.7.1 Eisai Basic Information
10.7.2 Eisai Neurologic Disorder Treatment Drug Product Overview
10.7.3 Eisai Neurologic Disorder Treatment Drug Product Market Performance
10.7.4 Eisai Business Overview
10.7.5 Eisai Recent Developments
10.8 F. Hoffmann La Roche
10.8.1 F. Hoffmann La Roche Basic Information
10.8.2 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Overview
10.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Market Performance
10.8.4 F. Hoffmann La Roche Business Overview
10.8.5 F. Hoffmann La Roche Recent Developments
10.9 H Lundbeck
10.9.1 H Lundbeck Basic Information
10.9.2 H Lundbeck Neurologic Disorder Treatment Drug Product Overview
10.9.3 H Lundbeck Neurologic Disorder Treatment Drug Product Market Performance
10.9.4 H Lundbeck Business Overview
10.9.5 H Lundbeck Recent Developments
10.10 Johnson and Johnson
10.10.1 Johnson and Johnson Basic Information
10.10.2 Johnson and Johnson Neurologic Disorder Treatment Drug Product Overview
10.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Product Market Performance
10.10.4 Johnson and Johnson Business Overview
10.10.5 Johnson and Johnson Recent Developments
10.11 Merck
10.11.1 Merck Basic Information
10.11.2 Merck Neurologic Disorder Treatment Drug Product Overview
10.11.3 Merck Neurologic Disorder Treatment Drug Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Novartis
10.12.1 Novartis Basic Information
10.12.2 Novartis Neurologic Disorder Treatment Drug Product Overview
10.12.3 Novartis Neurologic Disorder Treatment Drug Product Market Performance
10.12.4 Novartis Business Overview
10.12.5 Novartis Recent Developments
10.13 Otsuka Pharmaceutical
10.13.1 Otsuka Pharmaceutical Basic Information
10.13.2 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
10.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Market Performance
10.13.4 Otsuka Pharmaceutical Business Overview
10.13.5 Otsuka Pharmaceutical Recent Developments
10.14 Pfizer
10.14.1 Pfizer Basic Information
10.14.2 Pfizer Neurologic Disorder Treatment Drug Product Overview
10.14.3 Pfizer Neurologic Disorder Treatment Drug Product Market Performance
10.14.4 Pfizer Business Overview
10.14.5 Pfizer Recent Developments
10.15 Sanofi
10.15.1 Sanofi Basic Information
10.15.2 Sanofi Neurologic Disorder Treatment Drug Product Overview
10.15.3 Sanofi Neurologic Disorder Treatment Drug Product Market Performance
10.15.4 Sanofi Business Overview
10.15.5 Sanofi Recent Developments
10.16 Takeda Pharmaceutical
10.16.1 Takeda Pharmaceutical Basic Information
10.16.2 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
10.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Market Performance
10.16.4 Takeda Pharmaceutical Business Overview
10.16.5 Takeda Pharmaceutical Recent Developments
10.17 Teva Pharmaceutical Industries
10.17.1 Teva Pharmaceutical Industries Basic Information
10.17.2 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Overview
10.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Market Performance
10.17.4 Teva Pharmaceutical Industries Business Overview
10.17.5 Teva Pharmaceutical Industries Recent Developments
10.18 UCB
10.18.1 UCB Basic Information
10.18.2 UCB Neurologic Disorder Treatment Drug Product Overview
10.18.3 UCB Neurologic Disorder Treatment Drug Product Market Performance
10.18.4 UCB Business Overview
10.18.5 UCB Recent Developments
10.19 USWM
10.19.1 USWM Basic Information
10.19.2 USWM Neurologic Disorder Treatment Drug Product Overview
10.19.3 USWM Neurologic Disorder Treatment Drug Product Market Performance
10.19.4 USWM Business Overview
10.19.5 USWM Recent Developments
11 NEUROLOGIC DISORDER TREATMENT DRUG MARKET FORECAST BY REGION
11.1 Global Neurologic Disorder Treatment Drug Market Size Forecast
11.2 Global Neurologic Disorder Treatment Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neurologic Disorder Treatment Drug Market Size Forecast by Country
11.2.3 Asia Pacific Neurologic Disorder Treatment Drug Market Size Forecast by Region
11.2.4 South America Neurologic Disorder Treatment Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neurologic Disorder Treatment Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neurologic Disorder Treatment Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neurologic Disorder Treatment Drug by Type (2026-2035)
12.1.2 Global Neurologic Disorder Treatment Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neurologic Disorder Treatment Drug by Type (2026-2035)
12.2 Global Neurologic Disorder Treatment Drug Market Forecast by Application (2026-2035)
12.2.1 Global Neurologic Disorder Treatment Drug Sales (K MT) Forecast by Application
12.2.2 Global Neurologic Disorder Treatment Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurologic Disorder Treatment Drug Market Size by Type (M USD)
Table 4. Global Neurologic Disorder Treatment Drug Market Size by Application
Table 5. Neurologic Disorder Treatment Drug Market Size Comparison by Region (M USD)
Table 6. Global Neurologic Disorder Treatment Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neurologic Disorder Treatment Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neurologic Disorder Treatment Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neurologic Disorder Treatment Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorder Treatment Drug as of 2025)
Table 11. Global Market Neurologic Disorder Treatment Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neurologic Disorder Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurologic Disorder Treatment Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neurologic Disorder Treatment Drug Sales by Type (K MT)
Table 27. Global Neurologic Disorder Treatment Drug Market Size by Type (M USD)
Table 28. Global Neurologic Disorder Treatment Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Neurologic Disorder Treatment Drug Sales Market Share by Type (2020-2025)
Table 30. Global Neurologic Disorder Treatment Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Neurologic Disorder Treatment Drug Market Share by Type (2020-2025)
Table 32. Global Neurologic Disorder Treatment Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Neurologic Disorder Treatment Drug Sales (K MT) by Application
Table 34. Global Neurologic Disorder Treatment Drug Market Size by Application
Table 35. Global Neurologic Disorder Treatment Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Neurologic Disorder Treatment Drug Sales Market Share by Application (2020-2025)
Table 37. Global Neurologic Disorder Treatment Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neurologic Disorder Treatment Drug Market Share by Application (2020-2025)
Table 39. Global Neurologic Disorder Treatment Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Neurologic Disorder Treatment Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Neurologic Disorder Treatment Drug Sales Market Share by Region (2020-2025)
Table 42. Global Neurologic Disorder Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neurologic Disorder Treatment Drug Market Size by Region (2020-2025)
Table 44. North America Neurologic Disorder Treatment Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Neurologic Disorder Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neurologic Disorder Treatment Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Neurologic Disorder Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neurologic Disorder Treatment Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Neurologic Disorder Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neurologic Disorder Treatment Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Neurologic Disorder Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neurologic Disorder Treatment Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Neurologic Disorder Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neurologic Disorder Treatment Drug Production (K MT) by Region(2020-2025)
Table 55. Global Neurologic Disorder Treatment Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neurologic Disorder Treatment Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AbbVie Basic Information
Table 63. AbbVie Neurologic Disorder Treatment Drug Product Overview
Table 64. AbbVie Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AbbVie Business Overview
Table 66. AbbVie SWOT Analysis
Table 67. AbbVie Recent Developments
Table 68. Acadia Pharmaceuticals Basic Information
Table 69. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Overview
Table 70. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Acadia Pharmaceuticals Business Overview
Table 72. Acadia Pharmaceuticals SWOT Analysis
Table 73. Acadia Pharmaceuticals Recent Developments
Table 74. Acorda Therapeutics Biotechnology Basic Information
Table 75. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Overview
Table 76. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Acorda Therapeutics Biotechnology Business Overview
Table 78. Acorda Therapeutics Biotechnology SWOT Analysis
Table 79. Acorda Therapeutics Biotechnology Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Neurologic Disorder Treatment Drug Product Overview
Table 82. Bayer Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Biogen Basic Information
Table 86. Biogen Neurologic Disorder Treatment Drug Product Overview
Table 87. Biogen Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Biogen Business Overview
Table 89. Biogen Recent Developments
Table 90. CSK Basic Information
Table 91. CSK Neurologic Disorder Treatment Drug Product Overview
Table 92. CSK Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. CSK Business Overview
Table 94. CSK Recent Developments
Table 95. Eisai Basic Information
Table 96. Eisai Neurologic Disorder Treatment Drug Product Overview
Table 97. Eisai Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Eisai Business Overview
Table 99. Eisai Recent Developments
Table 100. F. Hoffmann La Roche Basic Information
Table 101. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Overview
Table 102. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. F. Hoffmann La Roche Business Overview
Table 104. F. Hoffmann La Roche Recent Developments
Table 105. H Lundbeck Basic Information
Table 106. H Lundbeck Neurologic Disorder Treatment Drug Product Overview
Table 107. H Lundbeck Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. H Lundbeck Business Overview
Table 109. H Lundbeck Recent Developments
Table 110. Johnson and Johnson Basic Information
Table 111. Johnson and Johnson Neurologic Disorder Treatment Drug Product Overview
Table 112. Johnson and Johnson Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Johnson and Johnson Business Overview
Table 114. Johnson and Johnson Recent Developments
Table 115. Merck Basic Information
Table 116. Merck Neurologic Disorder Treatment Drug Product Overview
Table 117. Merck Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck Business Overview
Table 119. Merck Recent Developments
Table 120. Novartis Basic Information
Table 121. Novartis Neurologic Disorder Treatment Drug Product Overview
Table 122. Novartis Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Novartis Business Overview
Table 124. Novartis Recent Developments
Table 125. Otsuka Pharmaceutical Basic Information
Table 126. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
Table 127. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Otsuka Pharmaceutical Business Overview
Table 129. Otsuka Pharmaceutical Recent Developments
Table 130. Pfizer Basic Information
Table 131. Pfizer Neurologic Disorder Treatment Drug Product Overview
Table 132. Pfizer Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Pfizer Business Overview
Table 134. Pfizer Recent Developments
Table 135. Sanofi Basic Information
Table 136. Sanofi Neurologic Disorder Treatment Drug Product Overview
Table 137. Sanofi Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Sanofi Business Overview
Table 139. Sanofi Recent Developments
Table 140. Takeda Pharmaceutical Basic Information
Table 141. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
Table 142. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Takeda Pharmaceutical Business Overview
Table 144. Takeda Pharmaceutical Recent Developments
Table 145. Teva Pharmaceutical Industries Basic Information
Table 146. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Overview
Table 147. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Teva Pharmaceutical Industries Business Overview
Table 149. Teva Pharmaceutical Industries Recent Developments
Table 150. UCB Basic Information
Table 151. UCB Neurologic Disorder Treatment Drug Product Overview
Table 152. UCB Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. UCB Business Overview
Table 154. UCB Recent Developments
Table 155. USWM Basic Information
Table 156. USWM Neurologic Disorder Treatment Drug Product Overview
Table 157. USWM Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. USWM Business Overview
Table 159. USWM Recent Developments
Table 160. Global Neurologic Disorder Treatment Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 161. Global Neurologic Disorder Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 163. North America Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 165. Europe Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Neurologic Disorder Treatment Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 167. Asia Pacific Neurologic Disorder Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 169. South America Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Neurologic Disorder Treatment Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 173. Global Neurologic Disorder Treatment Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Neurologic Disorder Treatment Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 175. Global Neurologic Disorder Treatment Drug Sales (K MT) Forecast by Application (2026-2035)
Table 176. Global Neurologic Disorder Treatment Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurologic Disorder Treatment Drug Market Size by Type (M USD)
Table 4. Global Neurologic Disorder Treatment Drug Market Size by Application
Table 5. Neurologic Disorder Treatment Drug Market Size Comparison by Region (M USD)
Table 6. Global Neurologic Disorder Treatment Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neurologic Disorder Treatment Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neurologic Disorder Treatment Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neurologic Disorder Treatment Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorder Treatment Drug as of 2025)
Table 11. Global Market Neurologic Disorder Treatment Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neurologic Disorder Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurologic Disorder Treatment Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neurologic Disorder Treatment Drug Sales by Type (K MT)
Table 27. Global Neurologic Disorder Treatment Drug Market Size by Type (M USD)
Table 28. Global Neurologic Disorder Treatment Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Neurologic Disorder Treatment Drug Sales Market Share by Type (2020-2025)
Table 30. Global Neurologic Disorder Treatment Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Neurologic Disorder Treatment Drug Market Share by Type (2020-2025)
Table 32. Global Neurologic Disorder Treatment Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Neurologic Disorder Treatment Drug Sales (K MT) by Application
Table 34. Global Neurologic Disorder Treatment Drug Market Size by Application
Table 35. Global Neurologic Disorder Treatment Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Neurologic Disorder Treatment Drug Sales Market Share by Application (2020-2025)
Table 37. Global Neurologic Disorder Treatment Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neurologic Disorder Treatment Drug Market Share by Application (2020-2025)
Table 39. Global Neurologic Disorder Treatment Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Neurologic Disorder Treatment Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Neurologic Disorder Treatment Drug Sales Market Share by Region (2020-2025)
Table 42. Global Neurologic Disorder Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neurologic Disorder Treatment Drug Market Size by Region (2020-2025)
Table 44. North America Neurologic Disorder Treatment Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Neurologic Disorder Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neurologic Disorder Treatment Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Neurologic Disorder Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neurologic Disorder Treatment Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Neurologic Disorder Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neurologic Disorder Treatment Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Neurologic Disorder Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neurologic Disorder Treatment Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Neurologic Disorder Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neurologic Disorder Treatment Drug Production (K MT) by Region(2020-2025)
Table 55. Global Neurologic Disorder Treatment Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neurologic Disorder Treatment Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Neurologic Disorder Treatment Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AbbVie Basic Information
Table 63. AbbVie Neurologic Disorder Treatment Drug Product Overview
Table 64. AbbVie Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AbbVie Business Overview
Table 66. AbbVie SWOT Analysis
Table 67. AbbVie Recent Developments
Table 68. Acadia Pharmaceuticals Basic Information
Table 69. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Overview
Table 70. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Acadia Pharmaceuticals Business Overview
Table 72. Acadia Pharmaceuticals SWOT Analysis
Table 73. Acadia Pharmaceuticals Recent Developments
Table 74. Acorda Therapeutics Biotechnology Basic Information
Table 75. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Overview
Table 76. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Acorda Therapeutics Biotechnology Business Overview
Table 78. Acorda Therapeutics Biotechnology SWOT Analysis
Table 79. Acorda Therapeutics Biotechnology Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Neurologic Disorder Treatment Drug Product Overview
Table 82. Bayer Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Biogen Basic Information
Table 86. Biogen Neurologic Disorder Treatment Drug Product Overview
Table 87. Biogen Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Biogen Business Overview
Table 89. Biogen Recent Developments
Table 90. CSK Basic Information
Table 91. CSK Neurologic Disorder Treatment Drug Product Overview
Table 92. CSK Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. CSK Business Overview
Table 94. CSK Recent Developments
Table 95. Eisai Basic Information
Table 96. Eisai Neurologic Disorder Treatment Drug Product Overview
Table 97. Eisai Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Eisai Business Overview
Table 99. Eisai Recent Developments
Table 100. F. Hoffmann La Roche Basic Information
Table 101. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Overview
Table 102. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. F. Hoffmann La Roche Business Overview
Table 104. F. Hoffmann La Roche Recent Developments
Table 105. H Lundbeck Basic Information
Table 106. H Lundbeck Neurologic Disorder Treatment Drug Product Overview
Table 107. H Lundbeck Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. H Lundbeck Business Overview
Table 109. H Lundbeck Recent Developments
Table 110. Johnson and Johnson Basic Information
Table 111. Johnson and Johnson Neurologic Disorder Treatment Drug Product Overview
Table 112. Johnson and Johnson Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Johnson and Johnson Business Overview
Table 114. Johnson and Johnson Recent Developments
Table 115. Merck Basic Information
Table 116. Merck Neurologic Disorder Treatment Drug Product Overview
Table 117. Merck Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Merck Business Overview
Table 119. Merck Recent Developments
Table 120. Novartis Basic Information
Table 121. Novartis Neurologic Disorder Treatment Drug Product Overview
Table 122. Novartis Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Novartis Business Overview
Table 124. Novartis Recent Developments
Table 125. Otsuka Pharmaceutical Basic Information
Table 126. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
Table 127. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Otsuka Pharmaceutical Business Overview
Table 129. Otsuka Pharmaceutical Recent Developments
Table 130. Pfizer Basic Information
Table 131. Pfizer Neurologic Disorder Treatment Drug Product Overview
Table 132. Pfizer Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Pfizer Business Overview
Table 134. Pfizer Recent Developments
Table 135. Sanofi Basic Information
Table 136. Sanofi Neurologic Disorder Treatment Drug Product Overview
Table 137. Sanofi Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Sanofi Business Overview
Table 139. Sanofi Recent Developments
Table 140. Takeda Pharmaceutical Basic Information
Table 141. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Overview
Table 142. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Takeda Pharmaceutical Business Overview
Table 144. Takeda Pharmaceutical Recent Developments
Table 145. Teva Pharmaceutical Industries Basic Information
Table 146. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Overview
Table 147. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Teva Pharmaceutical Industries Business Overview
Table 149. Teva Pharmaceutical Industries Recent Developments
Table 150. UCB Basic Information
Table 151. UCB Neurologic Disorder Treatment Drug Product Overview
Table 152. UCB Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. UCB Business Overview
Table 154. UCB Recent Developments
Table 155. USWM Basic Information
Table 156. USWM Neurologic Disorder Treatment Drug Product Overview
Table 157. USWM Neurologic Disorder Treatment Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. USWM Business Overview
Table 159. USWM Recent Developments
Table 160. Global Neurologic Disorder Treatment Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 161. Global Neurologic Disorder Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 163. North America Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 165. Europe Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Neurologic Disorder Treatment Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 167. Asia Pacific Neurologic Disorder Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 169. South America Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Neurologic Disorder Treatment Drug Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Neurologic Disorder Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Neurologic Disorder Treatment Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 173. Global Neurologic Disorder Treatment Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Neurologic Disorder Treatment Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 175. Global Neurologic Disorder Treatment Drug Sales (K MT) Forecast by Application (2026-2035)
Table 176. Global Neurologic Disorder Treatment Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neurologic Disorder Treatment Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurologic Disorder Treatment Drug Market Size (M USD), 2025-2035
Figure 5. Global Neurologic Disorder Treatment Drug Market Size (M USD) (2020-2035)
Figure 6. Global Neurologic Disorder Treatment Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurologic Disorder Treatment Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurologic Disorder Treatment Drug Product Life Cycle
Figure 13. Neurologic Disorder Treatment Drug Sales Share by Manufacturers in 2025
Figure 14. Global Neurologic Disorder Treatment Drug Revenue Share by Manufacturers in 2025
Figure 15. Neurologic Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neurologic Disorder Treatment Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurologic Disorder Treatment Drug Revenue in 2025
Figure 18. Industry Chain Map of Neurologic Disorder Treatment Drug
Figure 19. Global Neurologic Disorder Treatment Drug Market PEST Analysis
Figure 20. Global Neurologic Disorder Treatment Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neurologic Disorder Treatment Drug Market Share by Type
Figure 27. Sales Market Share of Neurologic Disorder Treatment Drug by Type (2020-2025)
Figure 28. Sales Market Share of Neurologic Disorder Treatment Drug by Type in 2025
Figure 29. Market Share of Neurologic Disorder Treatment Drug by Type (2020-2025)
Figure 30. Market Share of Neurologic Disorder Treatment Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neurologic Disorder Treatment Drug Market Share by Application
Figure 33. Global Neurologic Disorder Treatment Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Neurologic Disorder Treatment Drug Sales Market Share by Application in 2025
Figure 35. Global Neurologic Disorder Treatment Drug Market Share by Application (2020-2025)
Figure 36. Global Neurologic Disorder Treatment Drug Market Share by Application in 2025
Figure 37. Global Neurologic Disorder Treatment Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neurologic Disorder Treatment Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Neurologic Disorder Treatment Drug Market Size by Region (2020-2025)
Figure 40. North America Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Neurologic Disorder Treatment Drug Sales Market Share by Country in 2024
Figure 43. North America Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neurologic Disorder Treatment Drug Market Size by Country in 2024
Figure 45. U.S. Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neurologic Disorder Treatment Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Neurologic Disorder Treatment Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neurologic Disorder Treatment Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neurologic Disorder Treatment Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Neurologic Disorder Treatment Drug Sales Market Share by Country in 2024
Figure 53. Europe Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neurologic Disorder Treatment Drug Market Size by Country in 2024
Figure 55. Germany Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neurologic Disorder Treatment Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Neurologic Disorder Treatment Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neurologic Disorder Treatment Drug Market Size by Region in 2024
Figure 68. China Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neurologic Disorder Treatment Drug Sales and Growth Rate (K MT)
Figure 79. South America Neurologic Disorder Treatment Drug Sales Market Share by Country in 2024
Figure 80. South America Neurologic Disorder Treatment Drug Market Size and Growth Rate (M USD)
Figure 81. South America Neurologic Disorder Treatment Drug Market Size by Country in 2024
Figure 82. Brazil Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neurologic Disorder Treatment Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Neurologic Disorder Treatment Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neurologic Disorder Treatment Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neurologic Disorder Treatment Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neurologic Disorder Treatment Drug Production Market Share by Region (2020-2025)
Figure 103. North America Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Neurologic Disorder Treatment Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Neurologic Disorder Treatment Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neurologic Disorder Treatment Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neurologic Disorder Treatment Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Neurologic Disorder Treatment Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Neurologic Disorder Treatment Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Neurologic Disorder Treatment Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurologic Disorder Treatment Drug Market Size (M USD), 2025-2035
Figure 5. Global Neurologic Disorder Treatment Drug Market Size (M USD) (2020-2035)
Figure 6. Global Neurologic Disorder Treatment Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurologic Disorder Treatment Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurologic Disorder Treatment Drug Product Life Cycle
Figure 13. Neurologic Disorder Treatment Drug Sales Share by Manufacturers in 2025
Figure 14. Global Neurologic Disorder Treatment Drug Revenue Share by Manufacturers in 2025
Figure 15. Neurologic Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neurologic Disorder Treatment Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurologic Disorder Treatment Drug Revenue in 2025
Figure 18. Industry Chain Map of Neurologic Disorder Treatment Drug
Figure 19. Global Neurologic Disorder Treatment Drug Market PEST Analysis
Figure 20. Global Neurologic Disorder Treatment Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neurologic Disorder Treatment Drug Market Share by Type
Figure 27. Sales Market Share of Neurologic Disorder Treatment Drug by Type (2020-2025)
Figure 28. Sales Market Share of Neurologic Disorder Treatment Drug by Type in 2025
Figure 29. Market Share of Neurologic Disorder Treatment Drug by Type (2020-2025)
Figure 30. Market Share of Neurologic Disorder Treatment Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neurologic Disorder Treatment Drug Market Share by Application
Figure 33. Global Neurologic Disorder Treatment Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Neurologic Disorder Treatment Drug Sales Market Share by Application in 2025
Figure 35. Global Neurologic Disorder Treatment Drug Market Share by Application (2020-2025)
Figure 36. Global Neurologic Disorder Treatment Drug Market Share by Application in 2025
Figure 37. Global Neurologic Disorder Treatment Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neurologic Disorder Treatment Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Neurologic Disorder Treatment Drug Market Size by Region (2020-2025)
Figure 40. North America Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Neurologic Disorder Treatment Drug Sales Market Share by Country in 2024
Figure 43. North America Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neurologic Disorder Treatment Drug Market Size by Country in 2024
Figure 45. U.S. Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neurologic Disorder Treatment Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Neurologic Disorder Treatment Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neurologic Disorder Treatment Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neurologic Disorder Treatment Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Neurologic Disorder Treatment Drug Sales Market Share by Country in 2024
Figure 53. Europe Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neurologic Disorder Treatment Drug Market Size by Country in 2024
Figure 55. Germany Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neurologic Disorder Treatment Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Neurologic Disorder Treatment Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neurologic Disorder Treatment Drug Market Size by Region in 2024
Figure 68. China Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neurologic Disorder Treatment Drug Sales and Growth Rate (K MT)
Figure 79. South America Neurologic Disorder Treatment Drug Sales Market Share by Country in 2024
Figure 80. South America Neurologic Disorder Treatment Drug Market Size and Growth Rate (M USD)
Figure 81. South America Neurologic Disorder Treatment Drug Market Size by Country in 2024
Figure 82. Brazil Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neurologic Disorder Treatment Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Neurologic Disorder Treatment Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neurologic Disorder Treatment Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neurologic Disorder Treatment Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neurologic Disorder Treatment Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Neurologic Disorder Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neurologic Disorder Treatment Drug Production Market Share by Region (2020-2025)
Figure 103. North America Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Neurologic Disorder Treatment Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Neurologic Disorder Treatment Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Neurologic Disorder Treatment Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neurologic Disorder Treatment Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neurologic Disorder Treatment Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Neurologic Disorder Treatment Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Neurologic Disorder Treatment Drug Market Share Forecast by Application (2026-2035)
